B cell depletion promotes melanoma tumor growth in a CD4+ T cell–dependent manner
The Journal of Immunology · 17.03.2026 · 215 (3)
DOI: 10.1093/jimmun/vkag004 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 18.03.2026. Verfasst von Selin Oncul und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Lymphocyte Depletion, B-Lymphocytes, Regulatory, Melanoma. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Developmental Research Program award from the MD Anderson Melanoma Specialized Programs of Research Excellence, National Institutes of Health.
Abstract (Originalsprache)
B cells constitute ∼15% to 20% of tumor-infiltrating lymphocytes in melanoma. Their presence in the tumor microenvironment correlates with improved survival and enhanced response to immune checkpoint blockade therapy. Yet, the functional contribution of B cells to melanoma immunity remains unclear. In this study, we showed that both genetic and antibody-mediated B cell depletion significantly promoted melanoma progression in mice. Immune profiling revealed that, although B cell percentages were reduced, IL-10–producing B regulatory cells (Bregs) persisted after depletion. However, the persistence of Bregs alone cannot explain the impact of B cell depletion on enhancing melanoma growth, as codepletion of B cells and CD4+ T cells, despite similar Breg levels, did not promote melanoma progression. B cell depletion also resulted in the accumulation of PD-1+ B cells, CD4+ T cells, and monocytic myeloid-derived suppressor cells into the tumor microenvironment, alongside a reduction in IFN-γ+CD8+ T cells, CXCL13+CD8+ T cells, and M1-like macrophages. Notably, plasma cell deficiency did not affect tumor growth, indicating that B cell–mediated antitumor activity is independent of antibody production. The tumor-promoting effect of B cell loss was at least partially CD4+ T cell dependent, as codepletion of B cells and CD4+ T cells reversed this phenotype and B cell depletion did not enhance tumor growth in Nu/Nu mice lacking mature T cells. Taken together, our findings reveal an antitumor role of B cells in melanoma and demonstrate that their loss promotes tumor progression through reprogramming of the tumor immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Förderung
- NIH HHS
- Developmental Research Program award from the MD Anderson Melanoma Specialized Programs of Research Excellence
- National Institutes of Health
Zitieren
APA
Oncul, S., Lee, H., Singh, S., Yee, C., & Afshar-Kharghan, V. (2026). B cell depletion promotes melanoma tumor growth in a CD4+ T cell–dependent manner. The Journal of Immunology, 215(3). https://doi.org/10.1093/jimmun/vkag004
Vancouver
Oncul S, Lee H, Singh S, Yee C, Afshar-Kharghan V. B cell depletion promotes melanoma tumor growth in a CD4+ T cell–dependent manner. The Journal of Immunology. 2026;215(3). doi:10.1093/jimmun/vkag004
BibTeX
@article{Oncul2026,
author = {Oncul, Selin and Lee, Hani and Singh, Shailbala and Yee, Cassian and Afshar-Kharghan, Vahid},
title = {B cell depletion promotes melanoma tumor growth in a CD4+ T cell–dependent manner},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {3},
doi = {10.1093/jimmun/vkag004}
}
EUVIMED